£8m initiative to support cancer discovery
Yes brainer
Getting rare disease drugs past the brain’s self-defence
News
GENFIT highlights nangibotide potential in ACLF
Phase 2 data expected during 2027
NICE backs PADCEV and KEYTRUDA combination
Recommendation expands options for bladder cancer
First patient dosed in rectal cancer BT-001 trial
Phase 1 study targets hard-to-treat patients
Nxera signs $1.47bn AbbVie licensing deal
Agreement covers IBD drug candidate
Myeloma fund launches with £15m initial backing
Philanthropy initiative targets treatment innovation
Web Exclusives
True colours
The gold standard in spectroscopy
Trust issues
Specialty pharmacies – a guide to regulatory bodies and standards
Leader of the packs
3 Packaging Companies that offer custom pharmaceutical packaging solutions
Fertile ground
Top-rated pharmacies in northern Virginia for personalised fertility care
Magazine
Yes brainer
Getting rare disease drugs past the brain’s self-defence
Game changing
Pharmacies can stand out in the TikTok Shop supplements market
AI together now
Four realities reshaping HCP engagement strategies
Channelling discovery
Jelena Mann is Professor of Epigenetics at Newcastle Uni
Sharp focus
Who monitors AI medical devices following authorisation?
Basic instinct
Should pharma comms stop trying to make science ‘simple’?
Burnham ambition
Fifth member of The Smiths attempts to write a chorus
The great escape
Diabetes care tech has transformed now access must
Thought Leadership
Investor horizons ahead of CPHI 2026
Key CDMO trends shaping strategies in a shifting global market
Buried knowledge could cost pharma billions. Here’s how to fix it
A global pharmaceutical company already has the competitive report it needs. The problem is that the report is buried...
Building the future of clinical research around the patients it serves
Clinical research is entering a new era: advances in methodological approaches, the growing integration of real-world...
Evolution
Future-ready pharma teams: building knowledge and capability to navigate a changing NHS
Webinars
Appointments
Eric Muller
Lucid Group appointed Eric Muller as Chief Executive Officer
Andrew Fenny
Andrew Fenny has been appointed President of Pace Life Sciences
Khatera Alawi
DFE Pharma has made Khatera Alawi Global Director HR
Dr Mai-Britt Zocca
Elevara Medicines has appointed Dr Mai-Britt Zocca as CEO
